Philippines DTI Floats Blanket Ban on Open-Pod Vapes and E-Liquids, Seeks Public Input

Jan.29
Philippines DTI Floats Blanket Ban on Open-Pod Vapes and E-Liquids, Seeks Public Input
Philippines’ Department of Trade and Industry (DTI) is inviting stakeholder feedback on a draft Department Administrative Order (DAO) that would impose a blanket ban on open vape pods and e-liquids—covering use, manufacturing, importation, and distribution.

Key Points

 

  • Agency: Department of Trade and Industry (DTI)
  • Scope: Ban the use, manufacture, importation, and distribution of open pods and e-liquids
  • Risk focus: Use of uncertified e-liquids; accidental/intentional poisoning; dermal exposure; potential adulteration with illegal substances
  • Regulatory impact: DTI would immediately stop processing applications/renewals for Philippine Standard (PS) licenses covering open pods and e-liquids
  • Consultation deadline: Feb. 4, 2026

 


 

2Firsts, Jan 29, 2026

 

According to local reporting, the Philippines’ Department of Trade and Industry (DTI) is seeking stakeholder feedback on a draft Department Administrative Order (DAO) that would impose a blanket ban on open vape pods and e-liquids, citing consumer health and safety risks. The draft would prohibit the use, manufacturing, importation, and distribution of the targeted products.

 

DTI said the proposal is anchored on Republic Act No. 11900, the Vaporized Nicotine and Non-Nicotine Products Regulation Act, and is intended to curb the potential abuse of harmful substances. Open pods are refillable cartridges that allow users to manually add e-liquids, unlike pre-filled or closed systems. DTI argues the refillable setup can enable the use of uncertified e-liquids, raising risks including accidental or intentional poisoning and dermal exposure.

 

DTI also warned e-liquids could be adulterated or repurposed to contain illegal and harmful substances, referencing a recent “Tuklaw” cigarettes case in which vape products were found to contain synthetic cannabinoid components. Citing a World Health Organization (WHO) study, DTI added that prohibiting open-pod sales is recommended due to the products’ modifiable features and higher potential for abuse.

 

Under the draft DAO, DTI would immediately stop processing applications and renewals for Philippine Standard (PS) licenses covering open pods and e-liquids. PS licenses are issued by DTI to ensure products meet national quality and safety standards before being sold in the domestic market. DTI said its Office for the Special Mandate on Vaporized Nicotine and Non-Nicotine Products, their Devices, and Novel Tobacco Products (OSMV) will accept comments on the draft policy until Feb. 4, 2026.

 

DTI also noted it recently sought feedback on a separate draft DAO that would introduce mandatory permits for vape-related advertising and sales promotions, requiring an Advertisement Permit (AP) or Sales Promotion Permit (SPP) from OSMV before materials are released.

 

Image source: Manila Bulletin

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
On January 20, 2026, the U.S. Food and Drug Administration (FDA) posted meeting materials ahead of a virtual Tobacco Products Scientific Advisory Committee (TPSAC) meeting scheduled for January 22, 2026, to discuss modified risk tobacco product (MRTP) applications submitted by Swedish Match USA, Inc. for 20 ZYN nicotine pouch products.
Jan.21 by 2FIRSTS.ai
HB337 Moves Forward: Cigarette and Nicotine Taxes Set to Rise in Utah
HB337 Moves Forward: Cigarette and Nicotine Taxes Set to Rise in Utah
Utah lawmakers are advancing HB337, a bill that would raise the state cigarette tax by $2 per pack and restructure taxes on other nicotine products. The proposal replaces weight-based taxes with percentage-based rates and removes reduced rates for certain modified risk products. Supporters say it will curb youth tobacco use, while opponents warn of cross-border shopping and harm to consumers seeking alternatives.
Feb.17
Japan Tobacco Launches Nordic Spirit Nicotine Pouches in Japan; Nationwide Rollout Starts April 6
Japan Tobacco Launches Nordic Spirit Nicotine Pouches in Japan; Nationwide Rollout Starts April 6
Japan Tobacco (JT) has introduced the new Nordic Spirit nicotine pouch brand in Japan. The Cola Fizz Medium flavor began early sales on March 3, 2026 via the CLUB JT online shop, and will be rolled out sequentially from April 6 through nationwide channels including 7-Eleven, Lawson, and NewDays. The Berry Mix Medium flavor is expected to launch on CLUB JT around mid-March.
Mar.04 by 2FIRSTS.ai
Japan Tobacco Expands Heated Tobacco Customization Strategy with Artist-Led Limited Editions
Japan Tobacco Expands Heated Tobacco Customization Strategy with Artist-Led Limited Editions
Japan Tobacco has launched a limited-edition Ploom AURA front panel series in collaboration with musician Ichiro Yamaguchi, featuring five customized designs incorporating brass, Kutani ware, verdigris, kintsugi, and rosewood motifs. Two editions are available through retail channels, while three are distributed via a membership lottery system. The initiative highlights JT’s growing focus on exterior customization and design partnerships as part of its broader heated tobacco brand strategy.
Feb.11 by 2FIRSTS.ai
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s Federal Public Prosecutor’s Office (MPF) and health regulator Anvisa signed a cooperation protocol to strengthen enforcement against electronic smoking devices (DEFs) and expand health-risk awareness campaigns.
Feb.03 by 2FIRSTS.ai
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA Outlines Manufacturing Requirements as Critical to ENDS PMTA Success
FDA officials said manufacturing consistency is a core prerequisite for ENDS PMTA reviews, not a procedural formality. During its February 10, 2026 roundtable, the agency outlined expectations for quality management systems, manufacturing documentation, nicotine control, stability studies, and risk mitigation, emphasizing that robust manufacturing evidence underpins determinations of whether products are appropriate for the protection of public health.
Feb.11